查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1588568

全球大麻酚 (CBG) 軟糖市場 - 2024-2031

Global Cannabigerol (CBG) Gummies Market - 2024-2031
出版日期: | 出版商: DataM Intelligence | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023 年，全球大麻醇 (CBG) 軟糖市場規模達到 24.7 億美元，預計到 2031 年將達到 444 億美元，2024-2031 年預測期間複合年成長率為 43.5%。

大麻醇 (CBG) 軟糖是注入大麻醇的耐嚼糖果，大麻醇是大麻植物中發現的一種大麻素，不會產生精神作用。 CBG 通常被稱為“所有大麻素之母”，是衍生其他大麻素（例如 CBD（大麻二酚）和 THC（四氫大麻酚））的基礎化合物。

大麻酚 (CBG) 軟糖的配方含有特定量的 CBG 萃取物以及各種調味劑和甜味劑，使其成為對消費者有吸引力的選擇。它們有不同的品種，包括軟糖和硬糖，可以使用全譜、廣譜或分離形式的大麻素生產。

市場動態：

司機

大麻合法化與產品創新

全球大麻酚（CBG）軟糖市場的需求受到多種因素的推動。主要因素之一是大麻合法化和產品創新。大麻的合法化，無論是用於醫療還是娛樂目的，都大大擴大了大麻醇（CBG）等含有大麻素的產品的市場准入和消費者基礎。隨著越來越多的州和國家將大麻合法化，消費者有更多機會獲得更多種類的大麻衍生產品，包括 CBG 軟糖。這種可訪問性的增加鼓勵更多的人探索這些產品，從而促進市場成長。

本公司在 CBG 軟糖市場不斷創新，以滿足消費者對健康產品日益成長的需求。人們對使用天然植物成分而不是人工添加劑的產品更感興趣。為了滿足這項需求，該公司正在使用有機蔗糖、果膠以及螺旋藻和薑黃等來源的天然香料和色素來配製 CBG 軟糖。這種向清潔成分的轉變對於注重健康的消費者特別有吸引力，他們尋求更自然的方法來體驗 CBG 的潛在好處。

此外，合作夥伴關係和合作等關鍵參與者策略將推動大麻酚（CBG）軟糖市場的成長。例如，2022 年 6 月，Cronos Group Inc. 宣布，他們在生產八種培養大麻素的合作中已達到第三個生產力里程碑。利用 Ginkgo 的有機體設計平台，Cronos 成功實現了四氫大麻酚 (THCV) 的生產力目標，THCV 是一種大麻素，據信可以減輕 THC 的食慾刺激作用。獲得更多稀有大麻素將增強 Cronos 的創新管道並支持其商業化策略。

限制

高生產成本和監管挑戰等因素預計將阻礙市場發展。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 大麻合法化與產品創新
    • 限制
      • 生產成本高
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析

第 6 章：按類別

  • 大麻二酚 (CBD) 食用
  • 大麻醇 (CBG)
  • 大麻酚 (CBN)

第 7 章：按口味

  • 覆盆子汁
  • 草莓果汁
  • 櫻桃汁
  • 草莓泥
  • 覆盆子粉
  • 其他

第 8 章：按形式

  • 硬糖
  • 軟糖

第 9 章：按申請

  • 消炎劑
  • 神經保護
  • 焦慮和壓力管理
  • 睡眠輔助
  • 情緒調節
  • 其他

第 10 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 11 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 12 章：公司簡介

  • Curaleaf Holding Inc.
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • The Cronos Group
  • Charlotte's Web, Inc.
  • Rare Cannabinoid Company.
  • Lazarus Naturals Inc.
  • Hemptown Naturals
  • Green Roads LLC
  • Medterra
  • ENDOCA
  • Extract Labs

第 13 章：附錄

簡介目錄
Product Code: PH8705

Overview

The global cannabigerol (CBG) gummies market reached US$ 2.47 billion in 2023 and is expected to reach US$ 44.4 billion by 2031 growing with a CAGR of 43.5% during the forecast period 2024-2031.

Cannabigerol (CBG) gummies are chewy confections that are infused with cannabigerol, a cannabinoid found in the cannabis plant that does not produce psychoactive effects. Often called the "mother of all cannabinoids," CBG serves as a foundational compound from which other cannabinoids, such as CBD (cannabidiol) and THC (tetrahydrocannabinol), are derived.

Cannabigerol (CBG) gummies are formulated to contain a specific amount of CBG extract, along with various flavorings and sweeteners, making them an appealing choice for consumers. They come in different varieties, including soft and hard candies, and can be produced using full-spectrum, broad-spectrum, or isolated forms of cannabinoids.

Market Dynamics: Drivers

Legalization of cannabis and product innovations

The demand for the global cannabigerol (CBG) gummies market is driven by multiple factors. One of the primary factors is the legalization of cannabis and product innovations. The legalization of cannabis, whether for medical or recreational purposes, has significantly expanded the market access and consumer base for products containing cannabinoids like Cannabigerol (CBG). As more states and countries move to legalize cannabis, consumers have greater access to a wider variety of cannabis-derived products, including CBG gummies. This increased accessibility encourages more people to explore these products, contributing to market growth.

Companies are continuously innovating in the CBG gummies market to meet the growing consumer demand for wellness-oriented products. People are more interested in products that utilize natural, plant-based ingredients instead of artificial additives. In response to this demand, companies are formulating CBG gummies with organic cane sugar, fruit pectin, and natural flavors and colors derived from sources like spirulina and turmeric. This shift towards clean ingredients is particularly appealing to health-conscious consumers who seek a more natural approach to experiencing the potential benefits of CBG.

Moreover, key player strategies such as partnerships and collaborations would propel this cannabigerol (CBG) gummies market growth. For instance, in June 2022, Cronos Group Inc. announced that they had reached the third productivity milestone in their collaboration to produce eight cultured cannabinoids. Utilizing Ginkgo's organism design platform, Cronos has successfully met the productivity target for tetrahydrocannabivarin (THCV), a cannabinoid believed to mitigate the appetite-stimulating effects of THC. This access to additional rare cannabinoids will enhance Cronos' innovation pipeline and support its commercialization strategy.

Restraints

Factors such as high production costs, and regulatory challenges, are expected to hamper the market.

Segment Analysis

The global cannabigerol (CBG) gummies market is segmented based on category, flavor, form, application, and region.

The cannabigerol (CBG) segment accounted for approximately 66.4% of the global cannabigerol (CBG) gummies market share

The cannabigerol (CBG) segment is expected to hold the largest market share over the forecast period. Cannabigerol (CBG) gummies are typically made with natural ingredients, including fruit flavors, to enhance their taste and appeal to consumers. Each gummy contains a pre-measured dose of CBG, providing a consistent and convenient method for incorporating this cannabinoid into daily routines.

While CBG shows potential in promoting mental focus, supporting brain health, and fostering relaxation, further research is essential to fully understand its effects and therapeutic possibilities. Consumers should consult healthcare professionals before starting any new supplements or products.

Moreover, key players in the industry introduced innovative product launches that would propel this cannabigerol (CBG) gummies market growth. For instance, in April 2024, Rare Cannabinoid Company launched special 420 deals on its THC Mood Gummies and CBD oils, celebrating the cannabis culture and offering consumers affordable access to high-quality products. This promotion is particularly notable as it aligns with the 420 holiday, recognized in the cannabis community as a day to celebrate and advocate for cannabis use.

The THC Mood Gummies feature a blend of Delta-9-THC, CBG (cannabigerol), and CBD (cannabidiol), creating a unique edible designed to enhance mood while supporting physical wellness. Each gummy aims to provide a balanced experience, combining the euphoric effects of THC with the calming properties of CBG and CBD. This formulation is intended to offer users a natural way to manage stress and discomfort while promoting overall well-being.

Also, in October 2021, Cronos Group Inc. announced the launch of its SPINACH FEELZ Chill Bliss 2:1 THC|CBG gummy, marking a significant innovation in the cannabis edible market in Canada. This product is notable as it is the first cannabis gummy in Canada to incorporate both THC and cultured cannabigerol (CBG) derived from fermentation processes, rather than directly from the cannabis plant.

The Chill Bliss gummy is designed to provide a balanced experience, delivering 10 mg of THC and 5 mg of CBG per package, which contains two gummies. Available in a Pineapple Starfruit flavor, this product aims to offer consumers a sweet and enjoyable way to experience the effects of these cannabinoids.

Geographical Analysis

North America accounted for approximately 44.2% of the global cannabigerol (CBG) gummies market share

North America region is expected to hold the largest market share over the forecast period owing to the ongoing legalization of cannabis for medical and recreational purposes in numerous states across the U.S. has greatly broadened the market for CBG products. This legal environment enables consumers to access a diverse array of cannabinoid products, including CBG gummies, without the stigma that often accompanies illegal substances.

In this region, as awareness of cannabinoids increases, a growing number of consumers are recognizing the potential benefits of cannabigerol (CBG) gummies. In contrast to more well-known cannabinoids like CBD and THC, CBG is in more demand for its distinctive properties, including anti-inflammatory effects and neuroprotective advantages. This increased awareness is fueling demand for products infused with CBG.

Moreover, in this region, a major number of key players' presence, well-advanced healthcare infrastructure, innovative product launches, and rising customization & personalization of CBG gummies, would propel this cannabigerol (CBG) gummies market growth. For instance, in November 2023, in U.S. Rare Cannabinoid Company, a prominent innovator in the hemp industry, unveiled its innovative product THC + CBG Relief Gummies. This revolutionary edible combines the power of Delta-9-THC, CBG, and CBD, offering consumers a natural solution to support their physical well-being. Each gummy contains a potent blend of 2.5mg Delta-9-THC, 30mg CBG, and 10mg CBD in a delightful green apple flavor, with 30 gummies per bottle. This convenient and enjoyable formulation aims to provide the potential benefits of these cannabinoids for physical wellness.

Similarly, in December 2022, KANHA, a renowned cannabis brand, launched its CBG "Harmony" gummies, which are positioned as a high-end product within the cannabinoid market. Each package contains a total of 300 mg of lab-tested cannabinoids, featuring twice the CBG content compared to competing offerings. This elevated concentration of CBG is intended to provide enhanced therapeutic benefits for consumers interested in this lesser-known cannabinoid.

The Harmony gummies are specifically formulated to promote both mental and physical wellness, utilizing cannabis-derived terpenes that contribute to a more comprehensive effect. Made with real fruit flavors and all-natural ingredients, these gummies reflect KANHA's dedication to quality and consumer safety. Additionally, the incorporation of NANO technology in the formulation improves absorption, allowing effects to be felt as soon as 15 minutes after consumption.

Market Segmentation

By Category

  • Cannabidiol (CBD) Edible
  • Cannabigerol (CBG)
  • Cannabinol (CBN)

By Flavor

  • Raspberry Juice
  • Strawberry Juice
  • Cherry Juice
  • Strawberry Puree
  • Raspberry Powder
  • Others

By Form

  • Hard Candy
  • Soft Candy

By Application

  • Anti-Inflammatory
  • Neuroprotection
  • Anxiety and Stress Management
  • Sleep Aid
  • Mood Regulation
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • The rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Middle East and Africa

Competitive Landscape

The major global players in the cannabigerol (CBG) gummies market include Curaleaf Holding Inc., The Cronos Group, Charlotte's Web, Inc., Rare Cannabinoid Company., Lazarus Naturals Inc., Hemptown Naturals, Green Roads LLC, Medterra, ENDOCA, and Extract Labs among others.

Key Developments

  • In August 2024, nuEra, a prominent cannabis dispensary chain in Illinois, launched its innovative Alchemy Ratio product line, which includes both gummies and vape cartridges. This new series is crafted to provide consumers with a more balanced and therapeutic cannabis experience, delivering targeted relief through a carefully calibrated blend of cannabinoids.

Why Purchase the Report?

  • To visualize the global cannabigerol (CBG) gummies market segmentation based on category, flavor, form, application, and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of the cannabigerol (CBG) gummies market with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping is available in excel consisting of key products of all the major players.

The global cannabigerol (CBG) gummies market report would provide approximately 70 tables, 67 figures, and 184 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Category
  • 3.2. Snippet by Flavor
  • 3.3. Snippet by Form
  • 3.4. Snippet by Application
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Legalization of Cannabis and Product Innovations
    • 4.1.2. Restraints
      • 4.1.2.1. High Production Costs
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Category

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 6.1.2. Market Attractiveness Index, By Category
  • 6.2. Cannabidiol (CBD) Edible*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Cannabigerol (CBG)
  • 6.4. Cannabinol (CBN)

7. By Flavor

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 7.1.2. Market Attractiveness Index, By Flavor
  • 7.2. Raspberry Juice *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Strawberry Juice
  • 7.4. Cherry Juice
  • 7.5. Strawberry Puree
  • 7.6. Raspberry Powder
  • 7.7. Others

8. By Form

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2. Market Attractiveness Index, By Form
  • 8.2. Hard Candy*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Soft Candy

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Anti-Inflammatory*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Neuroprotection
  • 9.4. Anxiety and Stress Management
  • 9.5. Sleep Aid
  • 9.6. Mood Regulation
  • 9.7. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Flavor
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Curaleaf Holding Inc. *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. The Cronos Group
  • 12.3. Charlotte's Web, Inc.
  • 12.4. Rare Cannabinoid Company.
  • 12.5. Lazarus Naturals Inc.
  • 12.6. Hemptown Naturals
  • 12.7. Green Roads LLC
  • 12.8. Medterra
  • 12.9. ENDOCA
  • 12.10. Extract Labs

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us